Literature DB >> 15286802

Regulation of hypothalamic prohormone convertases 1 and 2 and effects on processing of prothyrotropin-releasing hormone.

Vanesa C Sanchez1, Jorge Goldstein, Ronald C Stuart, Virginia Hovanesian, Lihong Huo, Heike Munzberg, Theodore C Friedman, Christian Bjorbaek, Eduardo A Nillni.   

Abstract

Regulation of energy balance by leptin involves regulation of several neuropeptides, including thyrotropin-releasing hormone (TRH). Synthesized from a larger inactive precursor, its maturation requires proteolytic cleavage by prohormone convertases 1 and 2 (PC1 and PC2). Since this maturation in response to leptin requires prohormone processing, we hypothesized that leptin might regulate hypothalamic PC1 and PC2 expression, ultimately leading to coordinated processing of prohormones into mature peptides. Using hypothalamic neurons, we found that leptin stimulated PC1 and PC2 mRNA and protein expression and also increased PC1 and PC2 promoter activities in transfected 293T cells. Starvation of rats, leading to low serum leptin levels, decreased PC1 and PC2 gene and protein expression in the paraventricular nucleus (PVN) of the hypothalamus. Exogenous administration of leptin to fasted animals restored PC1 levels in the median eminence (ME) and the PVN to approximately the level found in fed control animals. Consistent with this regulation of PCs in the PVN, concentrations of TRH in the PVN and ME were substantially reduced in the fasted animals relative to the fed animals, and leptin reversed this decrease. Further analysis showed that proteolytic cleavage of pro-thyrotropin-releasing hormone (proTRH) at known PC cleavage sites was reduced by fasting and increased in animals given leptin. Combined, these findings suggest that leptin-dependent stimulation of hypothalamic TRH expression involves both activation of trh transcription and stimulation of PC1 and PC2 expression, which lead to enhanced processing of proTRH into mature TRH.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15286802      PMCID: PMC484982          DOI: 10.1172/JCI21620

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  81 in total

1.  Low dose leptin administration reverses effects of sustained weight-reduction on energy expenditure and circulating concentrations of thyroid hormones.

Authors:  Michael Rosenbaum; Ellen M Murphy; Steven B Heymsfield; Dwight E Matthews; Rudolph L Leibel
Journal:  J Clin Endocrinol Metab       Date:  2002-05       Impact factor: 5.958

2.  Thyrotropin-releasing hormone decreases leptin and mediates the leptin-induced pressor effect.

Authors:  Silvia I García; María S Landa; Patricia I Porto; Azucena L Alvarez; Mariano Schuman; Samuel Finkielman; Carlos J Pirola
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

3.  Accelerated substrate cycling: a new energy-wasting role for leptin in vivo.

Authors:  Shannon P Reidy; Jean-Michel Weber
Journal:  Am J Physiol Endocrinol Metab       Date:  2002-02       Impact factor: 4.310

4.  Thyrotropin-releasing hormone receptor (TRHR) gene is associated with essential hypertension.

Authors:  S I García; P I Porto; G Dieuzeide; M S Landa; T Kirszner; Y Plotquin; C Gonzalez; C J Pirola
Journal:  Hypertension       Date:  2001-09       Impact factor: 10.190

5.  Uncoupling protein-3 is a molecular determinant for the regulation of resting metabolic rate by thyroid hormone.

Authors:  P de Lange; A Lanni; L Beneduce; M Moreno; A Lombardi; E Silvestri; F Goglia
Journal:  Endocrinology       Date:  2001-08       Impact factor: 4.736

6.  Mortality in 7B2 null mice can be rescued by adrenalectomy: involvement of dopamine in ACTH hypersecretion.

Authors:  V Laurent; A Kimble; B Peng; P Zhu; J E Pintar; D F Steiner; I Lindberg
Journal:  Proc Natl Acad Sci U S A       Date:  2002-02-19       Impact factor: 11.205

7.  Divergent roles of SHP-2 in ERK activation by leptin receptors.

Authors:  C Bjørbaek; R M Buchholz; S M Davis; S H Bates; D D Pierroz; H Gu; B G Neel; M G Myers; J S Flier
Journal:  J Biol Chem       Date:  2000-11-20       Impact factor: 5.157

8.  Effect of precipitated morphine withdrawal on post-translational processing of prothyrotropin releasing hormone (proTRH) in the ventrolateral column of the midbrain periaqueductal gray.

Authors:  Eduardo A Nillni; Alison Lee; Gabor Legradi; Ronald M Lechan
Journal:  J Neurochem       Date:  2002-03       Impact factor: 5.372

9.  Disruption of PC1/3 expression in mice causes dwarfism and multiple neuroendocrine peptide processing defects.

Authors:  Xiaorong Zhu; An Zhou; Arunangsu Dey; Christina Norrbom; Raymond Carroll; Chunling Zhang; Virginie Laurent; Iris Lindberg; Randi Ugleholdt; Jens J Holst; Donald F Steiner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-07-26       Impact factor: 11.205

10.  A missense mutation disrupting a dibasic prohormone processing site in pro-opiomelanocortin (POMC) increases susceptibility to early-onset obesity through a novel molecular mechanism.

Authors:  Benjamin G Challis; Lynn E Pritchard; John W M Creemers; Jerome Delplanque; Julia M Keogh; Jian'an Luan; Nicholas J Wareham; Giles S H Yeo; Sumit Bhattacharyya; Phillipe Froguel; Anne White; I Sadaf Farooqi; Stephen O'Rahilly
Journal:  Hum Mol Genet       Date:  2002-08-15       Impact factor: 6.150

View more
  37 in total

1.  Ghrelin regulates hypothalamic prolyl carboxypeptidase expression in mice.

Authors:  Jin Kwon Jeong; Jung Dae Kim; Sabrina Diano
Journal:  Mol Metab       Date:  2013-01-11       Impact factor: 7.422

2.  Processing of proaugurin is required to suppress proliferation of tumor cell lines.

Authors:  Akihiko Ozawa; Adam N Lick; Iris Lindberg
Journal:  Mol Endocrinol       Date:  2011-03-24

3.  Central Sirt1 regulates body weight and energy expenditure along with the POMC-derived peptide α-MSH and the processing enzyme CPE production in diet-induced obese male rats.

Authors:  Nicole E Cyr; Jennifer S Steger; Anika M Toorie; Jonathan Z Yang; Ronald Stuart; Eduardo A Nillni
Journal:  Endocrinology       Date:  2014-04-28       Impact factor: 4.736

4.  Mechanisms by which the orexigen NPY regulates anorexigenic α-MSH and TRH.

Authors:  Nicole E Cyr; Anika M Toorie; Jennifer S Steger; Matthew M Sochat; Samantha Hyner; Mario Perello; Ronald Stuart; Eduardo A Nillni
Journal:  Am J Physiol Endocrinol Metab       Date:  2013-01-15       Impact factor: 4.310

Review 5.  The role of leptin in regulating bone metabolism.

Authors:  Jagriti Upadhyay; Olivia M Farr; Christos S Mantzoros
Journal:  Metabolism       Date:  2014-10-25       Impact factor: 8.694

6.  Effects of estradiol on cerebrospinal fluid levels of agouti-related protein in ovariectomized rhesus monkeys.

Authors:  Ennian Xiao; Andrea J Kim; Roxanne Dutia; Irene Conwell; Michel Ferin; Sharon L Wardlaw
Journal:  Endocrinology       Date:  2010-01-07       Impact factor: 4.736

7.  The proprotein convertase encoded by amontillado (amon) is required in Drosophila corpora cardiaca endocrine cells producing the glucose regulatory hormone AKH.

Authors:  Jeanne M Rhea; Christian Wegener; Michael Bender
Journal:  PLoS Genet       Date:  2010-05-27       Impact factor: 5.917

Review 8.  Regulation of the hypothalamic thyrotropin releasing hormone (TRH) neuron by neuronal and peripheral inputs.

Authors:  Eduardo A Nillni
Journal:  Front Neuroendocrinol       Date:  2010-01-13       Impact factor: 8.606

9.  Nescient helix-loop-helix 2 interacts with signal transducer and activator of transcription 3 to regulate transcription of prohormone convertase 1/3.

Authors:  Dana L Fox; Deborah J Good
Journal:  Mol Endocrinol       Date:  2008-03-20

10.  The obesity susceptibility gene Cpe links FoxO1 signaling in hypothalamic pro-opiomelanocortin neurons with regulation of food intake.

Authors:  Leona Plum; Hua V Lin; Roxanne Dutia; Jun Tanaka; Kumiko S Aizawa; Michihiro Matsumoto; Andrea J Kim; Niamh X Cawley; Ji-Hye Paik; Y Peng Loh; Ronald A DePinho; Sharon L Wardlaw; Domenico Accili
Journal:  Nat Med       Date:  2009-09-20       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.